New editable

Let REVVY CPQ keep track of the moving parts



Let your sales people spend their time in the field talking to customers – not wasting time trying to put together a jigsaw puzzle of complex products with lots of moving parts.


Putting together a quote for a complex or configurable product is simple in Revvy CPQ. Just select what you want from a list of options and add it to a quote. 

REVVY CPQ does the heavy lifting to make sure that all of the options are compatible and that all required parts are automatically added to the quote. The quote itself generates a sales bill of materials, so it’s easy to go from quote to close.


Download our Revvy Best Practices for Quoting Complex Products sheet to find out how.

Tired of hiring a programming team to code your product configurations?



Well, those days are over. Revvy CPQ makes it easy to create rules to control product configuration and to enforce your business policies. You don’t have to be a programmer to quickly add a rule saying that Option A only works with Option B but isn’t available with Option C. 


REVVY CPQ lets you put together configuration rules and immediately test them, so you can make sure that the product configuration works the way that you want.   


Download our Revvy Best Practices for Creating Configuration Rules sheet to find out how.


New editable


Revenue Management for Pharma



Revenue Management for Pharma



Revenue Management for Pharma

Stop Losses, Maximize Gain Revenue leakage causes pharmaceutical and medical device companies to lose nearly 4.4% of overall revenue annually. That’s more than $11 billion a year across the industry, - IDC.

pharma-story-mobile1.png

Stop Losses, Maximize Gain

Revenue leakage causes pharmaceutical and medical device companies to lose nearly 4.4% of overall revenue annually. That’s more than $11 billion a year across the industry, - IDC.

Your Needs: Our Specialty Regulatory changes, payer consolidation, and competitive pressures are eroding profits and creating challenges to effective contracting across the pharmaceutical industry. Boost Margins Increase Visibility Improve Financial Control Enhance Strategy Leading pharmaceutical and biotech companies are leveraging the advantages of the Model N Pharma Suite to maximize revenue, drive growth, and reduce compliance risk.

pharma-story-mobile2.png

Your Needs: Our Specialty

Regulatory changes, payer consolidation, and competitive pressures are eroding profits and creating challenges to effective contracting across the pharmaceutical industry.

  • Boost Margins

  • Increase Visibility

  • Improve Financial Control

  • Enhance Strategy

Leading pharmaceutical and biotech companies are leveraging the advantages of the Model N Pharma Suite to maximize revenue, drive growth, and reduce compliance risk.

The Top Choice for BioPharma Five of the world's biggest pharma companies use Model N: Novartis, Merck, Abbott, Amgen, Astrazeneca Six of the fastest growing biopharma companies use Model N: Actelion, Celgene, Gilead, Endo, Shire, Allergan

pharma-story-mobile3.png

The Top Choice for BioPharma

Five of the world’s biggest pharma companies use Model N: Novartis, Merck, Abbott, Amgen, Astrazeneca

Six of the fastest growing biopharma companies use Model N: Actelion, Celgene, Gilead, Endo, Shire, Allergan

Measureable ROI: Delivered The industry's only end-to-end suite gives you embedded best practices and robust analytics to help you further maximize your revenue and ROI

Measureable ROI: Delivered The industry's only end-to-end suite gives you embedded best practices and robust analytics to help you further maximize your revenue and ROI

Measureable ROI: Delivered

The industry’s only end-to-end suite gives you embedded best practices and robust analytics to help you further maximize your revenue and ROI.

Raise Your ROI 1% improvement in price translates to 11% increase in operating profits, according to McKinsey. By not only improving pricing, but also plugging revenue leakage, increasing efficiencies, and reducing risk you can expect an even larger return.

pharma-story-mobile5.png

Raise Your ROI

1% improvement in price translates to 11% increase in operating profits, according to McKinsey. By not only improving pricing, but also plugging revenue leakage, increasing efficiencies, and reducing risk you can expect an even larger return.